AzTrials
AzTrials

Systemic SclerosisESSE2016NCT03614208

Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.

A study testing Home-care rehabilitation group (HCRG) in people with Systemic Sclerosis, run by Universita di Verona at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Systemic sclerosis (SSc) is an uncommon chronic rheumatic disease with an unknown cause and unpredictable course. The inability, in addition to easy fatigability, starts a vicious circle that leads to a fast deterioration of physical conditions that cause a reduction of aerobic exercise capacity and, consequently, of… Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Systemic Sclerosis
What is being tested?
Home-care rehabilitation group (HCRG)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteItaly
Study dates
1 Feb 2017to 1 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosis of SSc according to the criteria of ACR
  • no hospitalizations in the previous 3 months
  • no change in anti-rheumatic treatment in the previous 3 months
  • signed informed consent

Who cannot join

  • heart failure staging in classes III or IV of New York Heart Association (NYHA)
  • pulmonary hypertension, defined by echocardiogram as a right ventricular systolic pressure ≥ 45mmHg
  • vital capacity (VC) ≤ 50% or diffusion lung capacity of carbon monoxide (DLCO) ≤ 30% of predicted values.
  • renal failure defined as a calculated glomerular filtration rate (GFR) < 30ml/min, in agreement with the staging of International Federation of National Kidney Foundations
  • inability to perform the rehabilitation program due to skeletal-muscle impairments or other illnesses
  • pregnancy or planned pregnancy in the next 6 months
Show all 11Show fewer
  • psychiatric disorders that prevent collaboration and adherence at the rehabilitation the program, including drug abuse
  • involvement in ongoing aerobic or anaerobic exercise programs
  • Drop out criteria:
  • the demonstration of ischemic heart disease after cardiopulmonary exercise testing performed at baseline
  • need to change the dosage or interruption of prostanoids used in the treatment of SSc during the 6 months of the treatment

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Azienda Ospedaliera, SSO respiratory pathophysiology Unit, Verona

    Verona, Italy/Verona, 37134

Other trials in Italy

About this study

Official title: Effects of an Individualized, Home-based Exercise Program for the Patient With Systemic Sclerosis, on Exercise Capacity, Hand Mobility and Quality of Life: a Randomized, Controlled Study.

Systemic sclerosis (SSc) is an uncommon chronic rheumatic disease with an unknown cause and unpredictable course. The inability, in addition to easy fatigability, starts a vicious circle that leads to a fast deterioration of physical conditions that cause a reduction of aerobic exercise capacity and, consequently, of health-related quality of life (HRQoL). Aerobic exercise has already been shown to be safe and effective in improving exercise capacity and HRQoL of patients with chronic cardiovascular and pulmonary diseases. However, few studies have evaluated the role of specific exercise programs on the muscular impairment in SSc. Nevertheless, the results obtained in preliminary reports are promising, and, for these reasons, the management of muscular impairment in SSc could include an appropriate rehabilitation program besides pharmaceutical and surgical treatments.

The primary aim of this study will be to evaluate the effect of an individualized exercise program performed at home on aerobic capacity evaluated by 6 minutes walking test.

Read more

Secondary aims will be to evaluate: 1- VO2max, measured by cardiopulmonary test; 2- the effect of the same program on the muscular strength of upper and lower limbs; 3- the efficacy of a self-administered stretching program for finger joint motion. Secondary aims will be also 1-to ascertain whether a comprehensive exercise program may affect, besides physical function, HRQoL; 2- and to evaluate the adherence during two periods of three months, one whit and one without supervision and reinforcement by a phone call.

All the patients with a diagnosis of SSc, according to the criteria of American College of Rheumatology (ACR), who attended the Rheumatologic outpatient clinic of our institution will be evaluated in order to participate in the rehabilitation program. The pneumological examination and two days of screening and testing will take place at the outpatient's clinic of Respiratory Medicine and Sport of our institution.

Read the detailed description

This will be a randomized, controlled, six months parallel group study. The flow chart of the study is reported in table 1. Participants initially will undergo 2 days of screening and testing. During the first visit patients will sign an informed consent, will undergo clinical assessment, pulmonary function testing, measurement of anthropometric data and body composition by bioimpedentiometry. They will perform a graded exercise test on a cycloergometer and will complete questionnaires to assess HRQoL (short form-36, SF-36) and functional abilities (health assessment questionnaire disability index, HAQ-DI). During the second visit, the participants will carry out the hand mobility in scleroderma test (HAMIS), six minutes walking test (6MWT), will undergo measurements of quadriceps and biceps strength, and handgrip test. After completion of testing and screening, patients who will meet the selection criteria will be randomly assigned to one of two groups 1) home-care rehabilitation group (HCRG); 2) control group (CG). The first group will begin a six months program of exercise training. The patients of the second group will be given generic recommendations to increase physical activity.

The patients in the first group, during a session in our outpatient clinic, will be instructed by a physiotherapist how to perform the physical exercise program at home. In particular, they will learn how to use the stationary bike and how to perform the exercises for upper limbs. Furthermore, the patient of the first group will be instructed how to fill in a card in which they will record the exercises performed daily. Throughout the first three months of the training period, the patients received a phone call from a physiotherapist once monthly, during which the adherence to exercise program will be reinforced. Particularly, it will be asked about the adherence to and the acceptance of exercise program, and the presence of side effects. Also, the control group will receive a phone call with the same schedule, but only in order to evaluate health status and to give a general recommendation about the positive effect of the aerobic exercise. From the third to the sixth month, both groups will not receive a monthly call, in order to evaluate the adherence to the program in the absence of supervision.

After 3 and 6 months, the subjects will undergo a complete 2 days of testing, using the same schedule described for a baseline.

The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.

A stationary cycle (Energetics ct220p, Neomark Sarl, Luxembourg) will be given to each patient for lower limb training. Each session will consist of three phases. In the first one, the patient will pedal for 5 minutes without inserting the brake. In the second phase, the patient will be instructed to set the brake at a load equal to 60% of the watts achieved at the peak of the maximal ergocycle exercise test. This phase consists in two periods of fifteen minutes divided by recovery interval of three minutes. It will be followed by five minutes of cool-down without load. The frequency of pedalling will be about 60 rotation/min during the second phase and less than 50 during the other phases.

For upper limbs training the patients will perform ten repetitions for three times that consists in lifting and lowering repeatedly a weight from the waist to the shoulders, alternating periods of exercise and three minutes of rest. The load will be calculated as the 60% of predicted 1-RM. Warm up and stretching of upper limbs, shoulders and neck will be performed before and after each exercise session respectively.

For the first two weeks, for both types of exercises of the program, the load will be reduced by 20%.

For finger stretching to the patients will be given written and illustrated instructions on self-administered exercises, and will be directed to perform it every day, both in the morning and in the evening.

During the rehabilitation period, the patients will report each day on a diary for each type of exercise whether the tasks were complete, partially or not executed which corresponds a score of 1, 0.5, 0 respectively.

The attendance rate at the training session will be calculated by the ratio between the amount of the score obtained from the diary and the scheduled sessions multiplied for 100.

Being tested
Home-care rehabilitation group (HCRG)
Keywords
Systemic sclerosis, Home based rehabilitation, Quality of life, Hand mobility, Exercise capacity
Medical subject headings
Scleroderma, Systemic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home-care rehabilitation group (HCRG)Behavioural

    Also called Experimental group

    The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.

Study groups in NCT03614208
Study groupRoleWhat they receive
Home-care rehabilitation group (HCRG)ExperimentalThe home-based exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week. For finger stretching the patients will be directed to perform it every day, both in the morning and in the evening. During the rehabilitation period, the patients will report each day on a diary for each type of exercise. They received a phone call monthly, only for the first 3 months, to encourage them about the adherence and investigate any problems with the exercise program.
Receives: Behavioral: Home-care rehabilitation group (HCRG)
Control groupNo interventionControl group was encouraged to perform the generic aerobic physical activity at the baseline. Also, they received a monthly phone call, only for the first 3 months, to encourage them about the importance of doing aerobic exercise.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Six minute walking test

    Evaluate aerobic capacity

    Measured: Up to six months

Secondary outcomes (9)
  1. Maximum oxygen consumption (VO2max)

    Evaluate the maximum volume of oxygen that a human can consume in the unit of time, measured by cardiopulmonary test

    Measured: Up to six months

  2. Handgrip strength

    Handgrip strength will be measured in kilograms using a hydraulic hand-held dynamometer (Saehan Corp., Masan, Korea).Will be recorded, for each hand, the best result between three attempts.

    Measured: Up to six months

  3. Muscular strength of upper limbs

    Biceps strength will be measured in kilograms by an isometric forearm flexion using a dynamometer (Kern CH50K50, Kern\&Sohn, Balingen, Germany) perpendicularly fixed on the floor. Will be recorded, for each arm, the best result between three attempts.

    Measured: Up to six months

  4. One repetition maximum (1-RM) of biceps strength

    One repetition maximum (1-RM) of biceps strength, expressed in kilograms, will be determinated by using the submaximal estimation method (predicted 1-RM) with the formula of Brzycke.

    Measured: Up to six months

  5. Muscular strength of lower limbs

    Quadriceps strength will be measured in kilograms by an isometric leg extension. The subject will be seated in an adjustable, straight-backed chair with the lower leg unsupported and the hip and knee flexed in a 90° angle, with an adjustable belt around the hips. Isometric leg extension strength will be measured by a dynamometer (Kern CH50K50, Kern \& Sohn, Balingen, Germany) applied with a strap around the ankle just proximal to malleoli. Will be recorded, for each lower limb, the best result between three attempts.

    Measured: Up to six months

  6. Hand Mobility in Scleroderma test (HAMIS-test)

    Evaluate finger joint motion and hand function

    Measured: Up to six months

  7. Short Form - 36 (SF-36)

    It is a self-reported questionnaire for evaluating the health status. It contains 36 items, measuring quality of life with two summary measures, a physical component score (PCS) and a mental component score (MCS).

    Measured: Up to six months

  8. Health assessment questionnaire - disability index (HAQ-DI)

    This questionnaire indicates the extent of functional abilities. It consists in 20 items divided into eight categories. For each one of the items the score can range from 0 (lack of disability) to 3 (complete disability).

    Measured: Up to six months

  9. Adherence to exercise program, only for treatment group

    Evaluate the adherence, using a diary, during two periods of three months, one whit and one without supervision and reinforcement by phone call

    Measured: Up to six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2018
  2. Study start1 Feb 2017
  3. Primary completion1 Mar 2018
  4. Study completion1 Mar 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single blind RCT with two parallel group
Masking
Single blind
Who is masked
Investigator
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03614208
Sponsor's protocol ID
ESSE2016
Acronym
ESSE2016
Status last verified
Aug 2018
First submitted
26 Jul 2018
Last updated
3 Aug 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Home-care rehabilitation group (HCRG) in people with Systemic Sclerosis, run by Universita di Verona at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Six minute walking test (time frame: Up to six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in